Predict your next investment

HEALTHCARE | Drug Development
cytopathfinder.comja

See what CB Insights has to offer

Stage

Series B | Alive

About Cytopathfinder, Inc.

Provider of transfection technology for facilitating target discovery and alternative pathway analysis. The company offers RNAi-based compound profiling technology for designing rational combination of drugs. The company offers the following services: siRNA Transfection (Cellular PGx), PGx-related Consultation and clinical development.

Cytopathfinder, Inc. Headquarter Location

5-1 Chiyoda-Ku

Tokyo, 102-0076,

Japan

03-5530-8086

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.